Background: Short adults have an increased risk of type 2 diabetes. Although adult height results from childhood growth, the effects of height and growth trajectories during childhood are sparsely investigated. We investigated sex-specific associations between childhood height, growth and adult type 2 diabetes, including potential influences of birthweight and childhood body mass index (BMI). Methods: We followed 292 827 individuals, born 1930-83, from the Copenhagen School Health Records Register in national registers for type 2 diabetes (11 548 men; 7472 women). Weights and heights were measured at ages 7-13 years. Hazard ratios (HR) of type 2 diabetes (age ≥30 years) were estimated without and with adjustment for birthweight and BMI. Results: In men, associations between height and type 2 diabetes changed from inverse for below-average heights at age 7 years to positive for above-average heights at 13 years. No consistent associations were observed among women. These associations were not affected by birthweight. After adjustment for BMI, below-average childhood heights were inversely associated with type 2 diabetes among men (HR range: 0.91-0.93 per z-score) but aboveaverage heights were not. Among women, after adjustment for BMI, below-and above-average heights in childhood were inversely associated with type 2 diabetes (HR range: 0.91-0.95). Greater height growth from 7 to 13 years was positively associated with type 2 diabetes in men and women. Conclusions: After adjustment for BMI, short childhood height at all ages and greater growth during childhood are associated with an increased risk of type 2 diabetes, suggesting that this period of life warrants mechanistic investigations.
In recent decades, the prevalence of diabetes increased dramatically in Denmark 1 and globally. 2 In 2014, the global prevalence of diagnosed diabetes was estimated at 9% among adults. 2 The increase is, to a large degree, driven by weight gain and obesity, which are key determinants for the development of type 2 diabetes. Diabetes is a well-known cause of premature death and disability with severe economic and personal consequences. 2 Prevention of diabetes is therefore essential.
Adult height is largely genetically determined, and it serves as a biological marker for many diseases with a positive association with cancer, and an inverse association with coronary heart disease and mortality. 3, 4 Associations between adult height and type 2 diabetes tend to show inverse associations, [5] [6] [7] [8] [9] [10] although there are inconsistencies across studies and by sex. [7] [8] [9] [10] [11] [12] [13] [14] Since adult height results from growth occurring in childhood, it is a period of life that warrants further investigation. Few studies have investigated the relationship between childhood height and adult type 2 diabetes. Results from the Helsinki Birth Cohort studies showed that individuals who developed type 2 diabetes were shorter than average until age 7 years.
taller than average at age 15 years. 16 Moreover, a fast growth in height between ages 7 and 15 years was associated with adult type 2 diabetes in this population. 16 During childhood, height is positively correlated with birthweight and adiposity 17 and we previously found that childhood body mass index (BMI; kg/m 2 ) is associated with adult type 2 diabetes. 18 Therefore, the association between childhood height and type 2 diabetes may change depending on these factors. Furthermore, the association between BMI and type 2 diabetes is non-linear and potentially stronger for women than men. Yet, the shape of the association between childhood height and type 2 diabetes in adulthood and whether this association differs by sex remains largely unknown. Knowledge of these associations would be informative for understating disease aetiology and for guidance of mechanistic investigations. The aim of this study was to examine sex-specific associations between childhood height and growth in height and type 2 diabetes throughout adulthood and the influence of birthweight and childhood BMI.
Methods
The Copenhagen School Health Record Register (CSHRR) is a population-based cohort containing computerised information on almost all Copenhagen school children (n = 372 636) born from 1930 to 1989 and attending public or private schools in Copenhagen. 19 The information was obtained from their health examinations that were mandatory and performed annually through 1983 and thereafter only at school entrance and exit unless the child had health problems. 19 Beginning in 1968, a personal identification number was assigned to all Danish residents. This number was recorded on the health records or later retrieved for children who left school before 1968. Information on vital status was obtained by linkage to the Danish Civil Registration System. For children born in 1936 and onwards birthweight was reported by the parents at the first school health examination and this has been shown to be a valid method in this population. 20 Weight and height were measured by school doctors or nurses and used to calculate BMI. Height and BMI values were transformed to z-scores based upon internal references using the Lambda Mu Sigma method. 21 To account for secular increases in height, the reference populations for height were birth cohort specific (5-year intervals). The BMI reference population was based on children born from 1955 to 1960, for whom the prevalence of obesity was low and stable. Information on inpatient and outpatient diagnoses of type 2 diabetes was obtained by linking the personal identification number to the National Patient Register (NPR). 22 This register contains complete hospital discharge diagnosis histories for somatic hospitals in Denmark since 1977, and for outpatient and emergency departments since 1995. 22 In Denmark, patients with type 2 diabetes are treated in general practice and at hospitals. The NPR only includes the latter contacts, which is reflected in moderate completeness (sensitivity: 64%). Nonetheless, the positive predictive value of a diagnosis of diabetes established through the NPR is high (97%). 23 Age at hospital admission was used to define age-at-diagnosis. Type 2 diabetes was defined by the International Classification of Diseases (ICD) 8th revision until 1994 (250) and ICD-10 thereafter (E11-E14). In 1987, the ICD-8 code 249 (insulin-dependent diabetes mellitus) was introduced in Denmark; thus prior to this, the ICD-8 code 250 included all forms of diabetes. As most individuals with type 1 diabetes are diagnosed before age 30 years, we restricted the lower bound for age-at-diagnosis to this age to reduce potential misclassification.
Among individuals eligible for analysis ( Figure S1 ), follow-up started on January 1, 1977 or age 30 years, whichever came later and ended at the date of a type 2 diabetes diagnosis, death, emigration, loss to follow-up, or December 31, 2013; whichever came first. In total, 148 037 men and 144 790 women were included in the analyses, corresponding to 94.7% of the starting population for this study.
The project was approved by the Danish Data Protection Agency. According to Danish law, ethical approval is not required for purely register-based studies.
Statistical analyses
Correlation analyses between height and BMI at ages 7-13 years were performed. We estimated age-and sex-specific associations between childhood height z-scores at each age from 7-13 years and the first hospital-based diagnosis of type 2 diabetes using Cox proportional hazards regressions for time-to-event outcomes with age as the time scale. Due to sex differences in the prevalence and comorbidities of type 2 diabetes analyses were conducted separately for men and women. All models were stratified by year of birth (1-year intervals) and age-at-diagnosis (tertiles: 30-47, 48-65, 66-83 years).
To assess the effect of height independently of BMI, all analyses were performed with and without adjustment for BMI. Taking our previous findings into account, 18 BMI was modelled with interactions between BMI and age-at-diagnosis (in tertiles) and birth cohorts (1930-47, 1948-65, 1966-83) , respectively, using piecewise linear splines with one knot at the 50th percentile corresponding to a z-score of 0. Non-linearity between height and type 2 diabetes was detected for men (all P ≤ 0.05 except at age 13 years in the BMI adjusted model [P = 0.19]), but not for women (all P > 0.2). Models using piecewise linear splines with one or three knots at the 50th or 25th, 50th, and 75th percentiles, respectively, were examined and showed that a model with one knot at the 50th percentile appropriately represents the shapes of the associations (not shown). Therefore, all analyses were performed with one knot point at a z-score of 0 using piecewise linear models; also for women. Potential interactions between height and BMI (</≥0 z-score), birth cohorts, and age-at-diagnosis were tested in nested models with and without crossproduct terms using a likelihood ratio (LR) test. We found limited indications of interactions between height and BMI, birth cohorts or age-at-diagnosis (Tables S1 and S2 ).
In the sub-sample of 222 178 individuals with available information ( Figure S2 ), we examined if adjusting for birthweight influenced the associations without adjustment for BMI and if height and birthweight interacted. No interactions between height and birthweight were observed (all P ≥ 0.06).
We analysed the association between childhood height growth and type 2 diabetes in a model including baseline height (height z-score at 7 years of age) and change in height z-score from 7 to 13 years of age. The results are presented per 0.5 unit increase in z-scores as few children change more than this. Potential interactions between height growth (</≥0 z-score) and height at ages 7 years (</≥0 z-score) on the risk of type 2 diabetes were investigated using LR tests.
In a sensitivity analysis, the analyses were repeated using the Danish National Diabetes Register, which is valid from 1995 until 2012. 1 In addition to the NPR, it includes register-based information from primary and secondary healthcare sources on chiropody treatments, frequency of blood glucose measurements and the purchase of antidiabetic drugs. 
Results
During 7 489 340 person-years of follow-up, 19 020 (7.8% men, 5.2% women) type 2 diabetes diagnoses were recorded in the NPR ( Table 1) . As expected, correlations between childhood height and BMI were weakly positive and slightly increased from ages 7 through 13 years (Table S3) .
For men, associations between childhood height and type 2 diabetes turned from a reversed J-shape at younger ages to a J-shape at older childhood ages ( Figure 1 , Table 2 ). Thus, being short at 7 years, being short or tall at age 10 years or being tall at 13 years increased the risk of type 2 diabetes. After adjustment for BMI (thus estimating the association in individuals with similar BMI), the association was inverse for below-average heights and no associations were observed with above-average heights ( Figure 1 , Table 2 ). Hence, adjustment for BMI attenuated the excess risk observed for tall boys at the older childhood ages in the unadjusted analyses.
For women, associations shifted from no associations to a tendency towards positive associations across the ages 7-13 years; thus, height was not consistently or significantly associated with type 2 diabetes ( Figure 1 , Table 2 ). After adjustment for BMI, inverse associations between childhood heights and type 2 diabetes were observed at all ages for heights below-and above-average ( Figure 1 , Table 2 ). Thus, adjustment for BMI changed the indications of positive associations seen at ages 10-13 years to inverse associations.
Restricting the sample to men and women with information on birthweight did not change the unadjusted associations and adjustment for birthweight minimally influenced the estimates (Table S4 ).
The average change in height z-score from 7 to 13 years was similar for men and women (Table 1) . For men and women, greater height growth from age 7 to 13 years was positively associated with type 2 diabetes (Table 3) . Before adjustment for change in Figure 1 . Association between height z-score at age 7, 10 and 13 years and type 2 diabetes. The x-axis is truncated to depict the inner 95% of the distribution. The grey shading represents the confidence intervals, which are depicted as the minimum and maximum values from the sets of sex-specific analyses.
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Paediatric and Perinatal Epidemiology, 2017, 31, 284-292 BMI, growth in height interacted with height at 7 years for men and women; growth in height among individuals with below-average height at age 7 years was more strongly associated with type 2 diabetes than growth in height among individuals with aboveaverage heights at age 7 years. For men and women, adjustment for BMI at age 7 and 13 years attenuated these associations, thus change in BMI explained some of the effects of height growth on type 2 diabetes. Nonetheless height growth was still positively associated with type 2 diabetes, although it was only statistically significant for men who were below-average in height at age 7 years (Table 3) . After adjustment for change in BMI the interaction between growth and height at 7 years only remained significant for men. In the sensitivity analysis using the Danish National Diabetes Register, results were generally similar to those using the NPR. One difference was that after adjustment for BMI, below-and above-average child heights were significantly and inversely associated with type 2 diabetes for women and men (Table S5) . Another difference was that the hazard ratio (HR) for growth were significant in all groups defined by sex and height at age 7 years also after adjustment for BMI (Table S6) .
Comment

Main findings
We found that men who were short at ages 7-9 years, short or tall at age 10-11 years or tall at ages 12-13 years had increased risks of type 2 diabetes. Adjustment for birthweight did not change the associations. In contrast, when the influence of BMI was taken into account, being short at any age from 7 to 13 years increased the risk of type 2 diabetes for men, whereas being tall in childhood was not associated with type 2 diabetes. For women, height was not consistently associated with type 2 diabetes, but after adjustment for BMI we found inverse associations. Moreover, we found that greater height growth was positively associated with type 2 diabetes for men and women, and that this association was attenuated with adjustment for BMI.
Limitations
Our study was restricted to individuals who were diagnosed with type 2 diabetes in a hospital. Patients with diabetes who were treated exclusively in the primary care sector and undiagnosed individuals were not included. Therefore, we likely capture only the more advanced clinical cases. In our study, just like the majority of previous studies, information on the exact age at onset of type 2 diabetes was unavailable. Our analyses used the age at a hospital diagnosis, which is likely biased towards a higher age than the actual age of onset, and this is reflected in the prevalence estimates we report for this study population. Nonetheless, the similarity of the sensitivity analysis using the Danish National Diabetes Register, which includes information from treatment in the primary sector and is assumed to cover more than 95% of all patients diagnosed with diabetes, adds to the validity of our findings. 24 Information on adult height or other explanatory factors such as waist circumference, socio-economic status or family history of diabetes was not available. However, it was not the aim to assess mediation through these factors. Moreover, they would introduce bias only if the association between child height and type 2 diabetes differed across these factors.
Strengths
In this study, we applied a life-course perspective and studied the association between carefully measured childhood heights and the development of type 2 diabetes throughout adulthood in a large ethnically homogenous population. 19 We studied the associations in men and women separately, whether the associations deviated from linearity, and as a novel approach we included an adjustment for BMI, because in childhood it is positively correlated with height. 17 Virtually, all Copenhagen school children were included in this study. 19 In combination with the minimal loss to follow-up due to the register linkage, this means that the potential effects of selection bias in our study were limited.
Interpretation
Studies of childhood height and type 2 diabetes in adulthood are scarce. Individuals from the Helsinki Birth Cohort Studies who developed type 2 diabetes were shorter until age 7 years, at which point they had caught up and were average in height. 15 Thereafter, they had faster growth and by age 15, they were taller than average. 16 These findings are in accordance with the observed change from an inverse to a positive association from ages 7 to 13 years before adjustment for BMI, particularly among men. We observed a positive association between greater height growth and type 2 diabetes. In the The HRs illustrate the relative risk per 0.5 unit increase in height z-score between age 7 and 13 years. E.g. a HR of 1.17 (95% CI 1.14, 1.20) in boys with height z-scores below average at 7 years means that the relative risk of adult type 2 diabetes increases by 17% per 0.5 unit increase in height z-score between age 7 and 13 years. A HR of 1.12 (95% CI 1.08, 1.15) in boys with height z-scores above average at 7 years means that the risk of adult type 2 diabetes increases by 12% per 0.5 unit increase in height z-score between age 7 and 13 years.
Finnish Studies, the odds ratio for type 2 diabetes was 1.44 (95% confidence interval 1.20, 1.72) per increase in height z-score between ages 7 and 15 years. 16 Few children grow this much, but if we express our results per 1 z-score increase in height, the associations are of similar strength before adjustment for BMI. In accordance with our findings, prior work on the CSHRR showed a positive association between growth in height during childhood and coronary heart disease that was attenuated by adjustment for BMI. 25 Hence, a pattern emerges that greater height growth in childhood increases the risk of cardio-metabolic diseases in adulthood and part of this may be explained by the effect of change in BMI.
There is a well-established correlation between height and BMI among children. 17 Overweight children may be taller due to advanced biological maturity or the correlation may be due to common determinants, namely genes and nutrition. 17 When the association between childhood height and type 2 diabetes is adjusted for BMI, the contribution from adiposity is teased out, 26 and the inverse associations strengthen.
It even changed the associations at ages 10-13 years from positive to inverse. This suggests that the observed increased risk of type 2 diabetes among tall children in the unadjusted analyses is due to a higher BMI and possibly a higher fat mass. 17 Future studies with direct measures of body fat mass are required to further disentangle the effects of body fat mass and lean mass. Studies of adult height and type 2 diabetes show heterogeneous results; one study showed inverse associations in both sexes, 5 whereas other studies report significant inverse associations only among men 7, 8 or women 9, 10 or no significant association in either sex 13, 14 or in a men-only or women-only study. 11, 12 A large Israeli, men-only study reported a HR of 0.88 for incident type 1 or type 2 diabetes per 5 cm greater height at age 30 years after adjustment for clinical and biochemical diabetes risk factors including BMI. 6 We found associations of comparable strength among men who had a height below average in childhood and slightly weaker associations among women. Similar to our findings for men, it has been found that the association between adult height and type 2 diabetes is inverse non-linear and this has more often been found for men [5] [6] [7] than for women, 9 whereas one study found no indications of non-linearity. 10 The pathophysiological mechanisms underlying associations between height and type 2 diabetes are not well understood. 11 Short stature in adulthood is associated with an increased risk of glucose intolerance which may increase the risk of diabetes 27 whereas taller adults have a larger muscle mass and this may protect against diabetes. Also, hormonal factors relevant to growth may be involved. Insulin like growth factor-1 (IGF-1) is correlated with childhood growth 28 and IGF-1 is inversely associated with impaired glucose tolerance in adults. 29 However, we cannot preclude that inadequate nutrition especially during childhood may contribute to explain the findings.
Children of parents with lower social status are generally shorter than those from a higher social status 30 and low socio-economic status is related to an increased risk of type 2 diabetes. 5 One study on adult height and type 2 diabetes found an inverse association only before adjustment for education, 13 whereas other studies found that the association persisted after adjustment for employment grade, 5 education 7 or socio-economic status and education. 6 Therefore, the association is likely not fully explained by differences in social status. Throughout the study period, there have been changes in the definition and assessment of diabetes and the mean height of the study population increased. Hence, it can be speculated whether associations between height and later health changed over time. However, we found that the association of height with type 2 diabetes was similar for all birth cohorts and across adult ages. Our findings indicate that short stature can be viewed as an indicator of type 2 diabetes risk. Although height per se is not modifiable, our findings suggest that just like with any other non-modifiable risk factor, increasing awareness of its potential effects in the medical and general community can allow individuals to change their other behaviours to help reduce the risk of type 2 diabetes. Although height may be less important than other risk factors such as BMI the observed associations have implications for understanding disease aetiology and highlight that these ages in childhood warrant mechanistic investigations. Studies have identified genes that are associated with adult height and type 2 diabetes. 31, 32 Future research should explore the determinants of height, the association between genetics that regulates height and type 2 diabetes risk and potential signalling pathways.
Conclusions
In conclusion, when BMI is taken into account, being short at any age from 7 to 13 years as well as greater growth in height during childhood increase the risk of type 2 diabetes later in life, suggesting that these factors independently of each other are involved in the aetiology of type 2 diabetes. The associations are not affected by birthweight. The mechanisms remain to be elucidated. The findings highlight the importance of promoting and protecting appropriate childhood nutrition to promote optimal growth in childhood.
Supporting Information
Additional Supporting Information may be found in the online version of this article at the publisher's web-site: Table S1 . Hazard ratios (HR) and 95% confidence intervals (CI) according to height z-scores below (<0) and above (≥0) the 50th percentile and body mass index (BMI) z-scores below (<0) and above (≥0) the 50th percentile at age 7-13 years in relation to type 2 diabetes for men and women adjusted for BMI. Table S2 . Interactions between height z-scores below (<0) and above (≥0) the 50th percentile and year of birth and age-at-diagnosis without and with adjustment for body mass index (BMI). Table S3 . Correlations between height and body mass index by sex and childhood age. Table S4 . Hazard ratios (HR) and 95% confidence intervals (CI) according to height z-scores below (<0) and above (≥0) the 50th percentile at age 7-13 years in relation to type 2 diabetes for men and women without and with adjustment for birthweight. Table S5 . Hazard ratios (HR) and 95% confidence intervals (CI) according to height z-scores below (<0) and above (≥0) the 50th percentile at age 7-13 years in relation to type 2 diabetes for men and women without and with adjustment for body mass index (BMI) using the National Diabetes Register. Table S6 . Hazard ratios (HR) and 95% confidence intervals (CI) of type 2 diabetes for 0.5 unit change in height z-score between age 7 and 13 years adjusted for baseline height (height at 7 years) and with and without adjustment for body mass index (BMI) at 7 and 13 years among women and men with height zscores below or above average at age 7 years using the National Diabetes Register. Figure S1 . Flow chart of eligible individuals and those included in the study. Figure S2 . Flow chart of eligible individuals and those included in the study using birthweight data.
